AFME logo

Affluent Medical SA Stock Price

ENXTPA:AFME Community·€62.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

AFME Share Price Performance

€0
-1.68 (-100.00%)
€0
-1.68 (-100.00%)
Price €0

AFME Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight risk with worrying balance sheet.

4 Risks
0 Rewards

Affluent Medical SA Key Details

€5.3m

Revenue

€4.4m

Cost of Revenue

€916.0k

Gross Profit

€15.7m

Other Expenses

-€14.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.37
17.39%
-279.97%
107.8%
View Full Analysis

About AFME

Founded
2011
Employees
76
CEO
Sebastien Ladet
WebsiteView website
www.affluentmedical.com

Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. The company offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. Affluent Medical SA was founded in 2011 and is headquartered in Aix-en-Provence, France.

Recent AFME News & Updates

Does Affluent Medical (EPA:AFME) Have A Healthy Balance Sheet?

Nov 01
Does Affluent Medical (EPA:AFME) Have A Healthy Balance Sheet?

Recent updates

No updates